EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer’s disease induced by intracerebroventricular injection of streptozotocin

Sevdenur Yazi, Berna Ozen, Bahar Buldu, Ebru Yalcin, Osman Karakose, Ozan Cakmak, Selenay Somunkiran, Hasan R Yananli, Umit S Sehirli, Ozlem Kirazli

Brain Structure and Function · 14.06.2026 · 231 (6)

DOI: 10.1007/s00429-026-03142-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Structure and Function, online erschienen am 14.06.2026. Verfasst von Sevdenur Yazi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Department of Anatomy, Marmara University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Canagliflozin, Alzheimer Disease, Dendrites, Hippocampus. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marmara University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) and diabetes mellitus (DM) share common pathophysiological features. However, the effects of antidiabetic drugs on neurodegeneration are not completely known. Canagliflozin, a novel option for DM treatment, is a dual inhibitor of sodium glucose co-transporter type 2 (SGLT2) and acetylcholinesterase. The aim of this study is to examine the morphological features of dendrites and dendritic spines of pyramidal neurons in hippocampus of AD model treated with canagliflozin. The model of AD was obtained by intracerebroventricular injection of streptozotocin. Then, the rats were divided into 3 groups: vehicle, donepezil, and canagliflozin. The injections were i.c.v. administered for 7 days. Behavioral tests were performed to evaluate memory, anxiety, and motor functions. Brain tissues were processed by Golgi impregnation method. Pyramidal neurons in the CA1 region were examined using Neurolucida software. Dendritic branching, total dendrite length, dendritic spine density, and dendritic spine types were analyzed. Compared to the vehicle group, the donepezil group and the canagliflozin group exhibited significantly higher dendritic branches ( p = 0.0273, p = 0.0195) and total dendrite length ( p = 0.0171, p = 0.0360), respectively. The total dendritic spine density ( p < 0.0001) and the mushroom-type dendritic spine density ( p = 0.0001) were significantly low in the donepezil group compared to the vehicle group. However, canagliflozin did not induce any significant alterations in the dendritic spine density. Canagliflozin treatment was as effective as donepezil treatment on hippocampal dendrite morphology. This morphological framework, indicating dendritic plasticity and remodeling, serve to better understand the cellular effects of canagliflozin. Therefore, our study may contribute to the development of novel strategies for therapy of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CanagliflozinAlzheimer DiseaseDendritesHippocampusSodium-Glucose Transporter 2 InhibitorsAnimalsMaleStreptozocinRatsDisease Models, AnimalDonepezilDendritic SpinesPyramidal CellsRats, WistarRats, Sprague-Dawley

Stichwörter der Autor:innen

Alzheimer’s diseaseCanagliflozinDendriteDendritic spineDonepezil

Substanzen

CanagliflozinStreptozocinDonepezilSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • School of Medicine, Department of Anatomy, Marmara University, Istanbul, Turkey.
  • Institute of Health Sciences, Marmara University, Istanbul, Turkey.
  • School of Medicine, Department of Medical Pharmacology, Mugla Sitki Kocman University, Mugla, Turkey.
  • School of Medicine, Marmara University, Istanbul, Turkey.
  • School of Medicine, Department of Medical Pharmacology, Marmara University, Istanbul, Turkey.
  • School of Medicine, Department of Anatomy, Marmara University, Istanbul, Turkey. ozlemsarioz@gmail.com.

Förderung

  • Marmara University

Zitieren

APA

Yazi, S., Ozen, B., Buldu, B., Yalcin, E., Karakose, O., Cakmak, O., Somunkiran, S., Yananli, H. R., Sehirli, U. S., & Kirazli, O. (2026). The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer’s disease induced by intracerebroventricular injection of streptozotocin. Brain Structure and Function, 231(6). https://doi.org/10.1007/s00429-026-03142-4

Vancouver

Yazi S, Ozen B, Buldu B, Yalcin E, Karakose O, Cakmak O, et al. The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer’s disease induced by intracerebroventricular injection of streptozotocin. Brain Structure and Function. 2026;231(6). doi:10.1007/s00429-026-03142-4

BibTeX
@article{Yazi2026,
  author = {Yazi, Sevdenur and Ozen, Berna and Buldu, Bahar and Yalcin, Ebru and Karakose, Osman and Cakmak, Ozan and Somunkiran, Selenay and Yananli, Hasan R and Sehirli, Umit S and Kirazli, Ozlem},
  title = {The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer’s disease induced by intracerebroventricular injection of streptozotocin},
  journal = {Brain Structure and Function},
  year = {2026},
  volume = {231},
  number = {6},
  doi = {10.1007/s00429-026-03142-4}
}
Kostenlos starten →